In this context, the purpose of these investigations was to test the hypothesis that endotoxemia modulates hepatic bioenergetics via regulation of mitochondrial respiration by alteration of mitochondrial quality control pathways and is dependent on an iNOS/NO-mtROS signaling network. The gene discussed is NOS2; the disease is serum lipopolysaccharide activity.